| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | EVP And President, Hematology | President, Hematology
2 companies
Ahmed Nadim is a President And CEO at Cullinan Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 8 sells.
Estimated insider holdings value: $8.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 23, 2025 | CGEM Cullinan Therapeutics, Inc. | President And CEO | Sell | 9,922 | $10.01 | $99,319.22 | -2.3% | +28.4% | - | |
| Feb 25, 2025 | CGEM Cullinan Therapeutics, Inc. | President And CEO | Sell | 12,529 | $8.53 | $106,872.37 | -2.8% | -8.6% | +67.8% | |
| Dec 24, 2024 | CGEM Cullinan Therapeutics, Inc. | President And CEO | Sell | 8,400 | $11.87 | $99,708.00 | -3.1% | -30.4% | -16.4% | |
| Dec 26, 2023 | CGEM Cullinan Therapeutics, Inc. | President And CEO | Sell | 4,272 | $9.24 | $39,473.28 | -3.7% | +76.2% | +34.2% | |
| Jun 28, 2023 | CGEM Cullinan Therapeutics, Inc. | President And CEO | Sell | 759 | $11.40 | $8,652.60 | -0.7% | -10.9% | +52.0% | |
| May 23, 2023 | CGEM Cullinan Therapeutics, Inc. | President And CEO | Sell | 707 | $9.15 | $6,469.05 | -0.6% | +15.3% | +153.2% | |
| Apr 25, 2023 | CGEM Cullinan Therapeutics, Inc. | President And CEO | Sell | 716 | $10.59 | $7,582.44 | -0.6% | -1.1% | +81.1% | |
| Mar 23, 2023 | CGEM Cullinan Therapeutics, Inc. | President And CEO | Sell | 706 | $10.51 | $7,420.06 | -0.6% | +21.9% | +57.0% | |
| Jun 6, 2022 | CGEM Cullinan Therapeutics, Inc. | President And CEO | Buy | 8,090 | $12.40 | $100,316.00 | New | +3.3% | +0.1% |